Clinical Cancer Research

EORTC Tolerance study update

EORTC Tolerance study update October 12, 2022 TRIAL UPDATE: The EORTC TOLERANCE is now open for patient enrollment in Spain. TOLERANCE is an international study with nine participating countries. We are proud to support our partner EORTC and would like to say thank you for the good collaboration. You can read more about Rising Tide’s support for the TOLERANCE trial here  Read …

EORTC Tolerance study update Read More »

RTFCCR wishes the KRAS kickers a successful KRAS Kickers Connect Event!

Congratulations EORTC to 60 years of therapeutic progress! September 30, 2022 Join us September 30 – October 1, 2022 for our 2nd KRAS Kickers Connect event in Charlotte, North Carolina! Attend the event in person or connect online to learn about the latest in research, clinical trials, and survivorship from esteemed experts and dedicated advocates …

RTFCCR wishes the KRAS kickers a successful KRAS Kickers Connect Event! Read More »

Congratulations EORTC to 60 years of therapeutic progress!

RTFCCR wishes the KRAS kickers a successful KRAS Kickers Connect Event! September 30, 2022 It is our honor and pleasure to partner with you on various projects and we are looking forward for more. We are celebrating with you today! More information about the organization and the celebration program: European Organisation For Research And Treatment …

Congratulations EORTC to 60 years of therapeutic progress! Read More »

Rising Tide Foundation for Clinical Cancer Research and Swiss Cancer Research Jubilee Award Ceremony

Rising Tide Foundation for Clinical Cancer Research and Swiss Cancer Research Jubilee Award Ceremony September 20, 2022 An award ceremony in honor of the winners of our 2022 Jubilee Award was held in Basel on Monday, September 12. The Jubilee Award – marking the milestones of the 10-year-anniversary of Rising Tide Foundation for Clinical Cancer …

Rising Tide Foundation for Clinical Cancer Research and Swiss Cancer Research Jubilee Award Ceremony Read More »

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS September 20, 2022 For our upcoming Grant Review Committee, we are looking for reviewers for clinical cancer research proposals.   We are searching for the following medical expertise:   Advanced gastrointestinal cancer management  Pancreatic surgery and pancreatic cancer management  Platinum-sensitive, recurrent epithelial ovarian cancer  In addition, we are looking …

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS Read More »

Welcome to Annie Ellis our new Patient Advisory Board Member

Welcome to Annie Ellis our new Patient Advisory Board Member September 2, 2022 This week we welcome a new Patient Advisory Board Member – Annie Ellis. As a cancer survivor, she brings invaluable experience and knowledge, and we are excited to work with her to improve patient involvement in cancer research. Annie Ellis contributes patient …

Welcome to Annie Ellis our new Patient Advisory Board Member Read More »

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program August 30, 2022 With the support of Rising Tide Foundation for Clinical Cancer Research (RTFCCR), City of Hope, one of the largest cancer research and treatment organizations in the United States, will launch five coordinated, high-quality research …

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program Read More »

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE July 28, 2022 TRIAL UPDATE: First patient was enrolled in the EORTC TOLERANCE academic clinical trial in elderly patients with advanced soft tissue sarcoma. TOLERANCE is an international study with 9 participating countries. We are proud to support our partner EORTC and would like to say thank you for the good collaboration. You can …

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE Read More »

Scroll to Top